We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

101 hedge funds and large institutions have $317M invested in iShares US Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 47 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $860K | Put options by funds: $391K

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

6% more funds holding

Funds holding: 95 → 101 (+6)

0.25% more ownership

Funds ownership: 148.22% → 148.47% (+0.25%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less capital invested

Capital invested by funds: $348M → $317M (-$30.7M)

66% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 47

Holders
101
Holders Change
+6
Holders Change %
+6.32%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
16
Reduced
47
Closed
6
Calls
$860K
Puts
$391K
Net Calls
+$469K
Net Calls Change
+$469K

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$9.64M
2
Morgan Stanley
Morgan Stanley
New York
+$9.25M
3
Citadel Advisors
Citadel Advisors
Florida
+$6.13M
4
Jane Street
Jane Street
New York
+$4.76M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.53M

Top Sellers

Rank Fund Capital Flow
1
CI
Clal Insurance
Israel
-$21.9M
2
PAG
Pinnacle Advisory Group
Maryland
-$20.6M
3
Goldman Sachs
Goldman Sachs
New York
-$7.7M
4
Bank of America
Bank of America
North Carolina
-$7.41M
5
ST
Spinnaker Trust
Maine
-$6.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
76
Wealthspire Advisors (Maryland)
Maryland
$78K – – –
VFA
77
Valeo Financial Advisors
Indiana
$65K +$63.8K +1,242 New
FANJ
78
Financial Architects (New Jersey)
New Jersey
$59K +$308 +6 +0.5%
FCMT
79
Founders Capital Management (Texas)
Texas
$44K – – –
HNB
80
Huntington National Bank
Ohio
$39K – – –
WTC
81
WhitTier Trust Company
Nevada
$39K – – –
FFW
82
Fusion Family Wealth
New York
$27K – – –
GWM
83
Geneos Wealth Management
Colorado
$24K +$23.7K +462 New
GRP
84
Global Retirement Partners
California
$20K +$20K +390 New
Northwestern Mutual Wealth Management
85
Northwestern Mutual Wealth Management
Wisconsin
$18K -$6.16K -120 -26%
AA
86
AlphaMark Advisors
Kentucky
$18K – – –
JCM
87
Jacobi Capital Management
Pennsylvania
$17K – – –
CDIA
88
Capital Directions Investment Advisors
Georgia
$16K – – –
DSC
89
Duncker Streett & Co
Missouri
$16K – – –
EDRH
90
Edmond de Rothschild Holding
Switzerland
$16K +$15.4K +300 New
Fifth Third Bancorp
91
Fifth Third Bancorp
Ohio
$14K – – –
Manulife (Manufacturers Life Insurance)
92
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$14K +$14K +273 New
BONST
93
Bank of Nova Scotia Trust
Ontario, Canada
$13K +$12.3K +240 New
AIM
94
Anchor Investment Management
South Carolina
$9.38K +$9.24K +180 New
WIM
95
Westside Investment Management
California
$8.73K – – –
BWL
96
Bogart Wealth LLC
Virginia
$7K +$7.24K +141 New
CFD
97
Creative Financial Designs
Indiana
$6K – – –
BC
98
Bartlett & Co
Ohio
$5K – – –
TCM
99
Tradewinds Capital Management
Washington
$4K +$3.7K +72 New
TFA
100
Transamerica Financial Advisors
Florida
$2K -$336K -6,537 -100%
1 2 3
4
5

IHE Hedge Fund Activity: Q3 2017 in Review

101 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2017, worth a combined $317M — down 8.8% from $348M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IHE positions and 6 closed out — a net gain of 7 holders — while 16 added to existing stakes and 47 trimmed.

The largest buyer was Two Sigma Securities, adding an estimated $9.64M. The largest seller was Clal Insurance, cutting an estimated $21.9M.

  • 101 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2017, up from 95 in Q2 2017.
  • Funds reported $317M of iShares US Pharmaceuticals ETF stock for Q3 2017, down 8.8% quarter-over-quarter.
  • 13 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2017 and 6 closed out, a net change of +7 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2017 was Two Sigma Securities, an estimated $9.64M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2017 was Clal Insurance, an estimated $21.9M sold.

Based on aggregated 13F filings for Q3 2017.